Decreased levels of CHGB-derived peptides have been discovered in the cerebrospinal fluid of multiple sclerosis (MS) patients by Mo et al., who showed that, within a model of multiple sclerosis for mice, CGB levels were elevated in the neurons prior to the onset of MS symptoms. The gene discussed is CHGB; the disease is multiple sclerosis.